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ABSTRACT
Obesity during pregnancy is associated with a high risk of adverse maternal
outcomes. Little is known about how weight change between consecutive pregnancies
impacts subsequent pregnancy complications and newborn outcomes. This study aimed
to explore the association between interpregnancy BMI change and adverse maternal
outcomes, specifically, gestational diabetes mellitus (GDM), gestational hypertension,
pre-eclampsia, non-repeat cesarean delivery (C-section), and vaginal birth after cesarean
delivery (VBAC). The study sample was derived from the Eunice Kennedy Shriver
National Institute of Child Health and Human Development Consecutive Pregnancy
Study, which collected data from 20 hospitals in Utah utilizing electronic medical records
and International Classification of Diseases ninth revision codes. The study collected
extensive information on maternal demographic, reproductive and medical history,
pregnancy complications, and labor and delivery information. Women with at least two
pregnancies during the study period who delivered between 2002-2010 were included
(n=51,086 women yielding 114,679 pregnancies). After data exclusions, the study sample
included 46,521 women and the outcomes of their first two pregnancies. Between their
first two consecutive pregnancies, these women gained an average of 0.81 BMI units
(interquartile range (IQR) -0.34 to 1.77) over an average interpregnancy interval of 634
days (IQR 373 to 814). Poisson regression with robust variance estimators was utilized to
estimate the relative risks of the outcomes. After adjusting for potential confounders,
every one unit increase in BMI between consecutive pregnancies increased the risk of
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GDM (relative risk (RR): 1.09 (95% confidence interval (CI): 1.07 – 1.11)), preeclampsia (RR: 1.06 (95% CI: 1.04 – 1.09)), and gestational hypertension in the second
pregnancy increased (RR: 1.08 (95% CI: 1.06 – 1.10). For every one unit increase in
BMI, the risk of having a successful VBAC decreased (RR: 0.95 (95% CI: 0.93 – 0.98)).
There was no significant association seen between interpregnancy BMI change and a
non-repeat C-section. Women with a BMI ≥ 3 units increase were also at a significantly
increased risk of GDM (RR: 1.72 (95% CI: 1.52 – 1.93)), pre-eclampsia (RR: 1.61 (95%
CI: 1.33 – 1.94)), and gestational hypertension (RR: 1.66 (95% CI: 1.42 – 1.93)) in the
second pregnancy when compared to women who maintained their BMI between
pregnancies (- 1 unit ≤ BMI change < 1 unit). The risk of having a successful VBAC
decreased (RR: 0.72 (95% CI: 0.58 – 0.88) for women who gained ≥ 3 units, compared to
women who maintained their BMI (- 1 unit ≤ BMI change < 1 unit). GDM was also
increased among those who increased their BMI by at least 2 units but not more than 3
units (RR: 1.40 (95% CI: 1.22 – 1.61)) and among those who gained at least 1 unit but no
more than 2 BMI units (RR: 1.23 (95% CI: 1.08 – 1.40)). These findings have public
health implications for the importance of weight management between pregnancies.
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CHAPTER 1
INTRODUCTION
Nearly 56% of reproductive aged women (20-39 years of age) are overweight or obese1.
Obesity during pregnancy is associated with a high risk of maternal and newborn adverse
outcomes. Less is known about how weight change between two consecutive
pregnancies, hereafter known as interpregnancy BMI or weight change, impacts
subsequent pregnancy complications and newborn outcomes. In 2012, 41.6% of 15-50
year old women in the US reported having two or more children2; thus, investigating the
association between interpregnancy weight change and pregnancy complications is
important. The best evidence for the impact of interpregnancy weight change on maternal
health (pre-eclampsia, gestational hypertension, gestational diabetes mellitus (GDM), and
cesarean delivery) comes from a study by Villamor and Cnattingius (2006)3.
Using data from the Swedish Birth Register (n=151025 women), Villamor et al
defined outcomes using the International Classifications of Diseases (ICD) ninth and
tenth revisions3. They categorized the exposure into groups based on the participant’s
change in BMI units from the first to the second pregnancy (range: >1 BMI unit decrease
to ≥ 3 unit increase)3. Using logistic regression models, they found significant
associations in the odds of pre-eclampsia [odds ratio (OR): 1.78; 95% confidence interval
(CI): 1.52 – 2.08)]; gestational hypertension [OR: 1.76; 95% CI: 1.39 – 2.23]; GDM [OR:
2.09; 95% CI: 1.68 – 2.61]; and cesarean section [OR: 1.32; 95% CI: 1.22 – 1.44] when
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comparing women with an interpregnancy BMI gain of 3 or more units to women with a
change of -1 to 0.9 units3. These main findings are in line with the overall findings of
subsequent studies4-12, 14, 15, which show that there is a positive association between an
increase in intrepregnancy BMI and the risk of maternal adverse health outcomes.
Studies similar to the Villamor and Cnattingius3 study have been conducted in the
US. These studies utilized vital records data from Missouri4-9 or Washington10, 11 or had
hospital-based cohort data12. Studies that used the vital statistics data examined the
change in pre-pregnancy BMI between the first and second pregnancies as the exposure,
which was categorized in different ways. One Missouri study, Mostello et al (2010)7,
used the following categories: those who decreased their BMI ≥ 2 units; those who
increased their BMI ≥ 2 units; and those who maintained their BMI within ± 2 units. The
other Missouri studies4-6, 8, 9 utilized World Health Organization BMI categories13
[underweight (BMI <18.5 kg/m2); normal (BMI: 18.50 – 24.99); overweight (BMI: 25.00
– 29.99); obese (BMI ≥ 30.00)] classifying women based on their first and second prepregnancy BMI. For example, a woman who has a normal BMI at the start of her first
pregnancy and was overweight at the start of her second pregnancy would be classified as
“normal-overweight”4-6, 8, 9. All of the studies adjusted for the first prepregnancy BMI
group in their models along with other potential confounders4-5, 7-9. One study6 restricted
their analysis to only include women whose first prepregnancy BMI was classified as
overweight. The overall findings of the Missouri4-9 cohort studies illustrate that there is a
positive association with interpregnancy BMI increase and the risk of adverse maternal
outcomes in the second pregnancy/delivery; the exclusion criteria and findings of these
studies are reported in Tables 1.1 and 1.2.
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Vital records data from Washington State10, 11 have also been used to investigate
the association between interpregnancy BMI change and adverse maternal outcomes.
Paramsothy et al (2009)10 investigated the association between interpregnancy weight
change and cesarean section in the second pregnancy among women with GDM using
data collected from 1992-2005 (n=2753). Unlike the previously described studies, they
categorized their exposure as weight change in pounds: weight loss greater than 10
pounds (lbs); weight maintained (±10 lbs); weight gain of greater than 10 lbs and
reported a significant association in the odds of having a cesarean delivery in the second
pregnancy (OR: 1.70, 95% CI: 1.16 – 2.49) between women who gained more than 10 lbs
and women with weight gain <10 lbs10. Another study utilizing data from Washington’s
vital records was done by Callegari et al (2014)11. They investigated the association
between interpregnancy BMI change and vaginal birth after cesarean section (VBAC)
utilizing data from 1992-2009 (n=8302)11. They categorized the exposure as follows: <1
BMI unit decrease or increase; ≥ 1 BMI unit decrease; ≥ 1 and < 2 units increase; ≥ 2
BMI units increase11. This study found that those with normal BMI before their first
pregnancy had an 8% decrease in VBAC success with ≥ 1 and <2 BMI unit increase and
a 12% decrease in success with ≥ 2 BMI unit increase compared with normal BMI
women who maintained their weight11. The results of these studies10, 11 further support
the overall finding that an increase in interpregnancy weight is associated with an
increased risk of adverse maternal outcomes in the second delivery, specifically GDM
and VBAC.
All of the studies enumerated above3-11 list the source of their data as a limitation.
Vital records underreport the incidence of maternal complications compared to medical
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records27-30. DiGiuseppe et al (2002)27 utilized kappa statistics to investigate the
agreement between vital records and medical records. For maternal risk factors and
comorbidities, they report kappa statistics ranging from 0.085 – 0.54527. Additionally, for
several complications of pregnancy and/or labor and delivery, they report kappa statistics
ranging from 0.285 – 0.73427. Further, DiGiuseppe et al found high specificity (sp) for
maternal risk factors, comorbidities, and pregnancy and/or labor and delivery
complications (sp: 96.5 – 99.9%)27. In this instance, specificity is the probability that an
individual did not report the outcome given that he or she did not have it. However, the
same maternal risk factors, comorbidities, and complications resulted in lower
sensitivities, which ranged from 8.6 – 65.4%27. Here, sensitivity is the probability that an
individual reported the outcome given that he or she had it. Whether it is better to have a
high sensitivity or specificity depends on the outcome, risk factor, or comorbidity of
interest. DiGiuseppe et al conclude that utilizing vital records as opposed to medical
records as a source for this type of data is ‘suspect’ at best27.
To our knowledge, only one study in the US utilized a hospital-based cohort
investigating the association between interpregnancy BMI change and GDM. Ehrlich et
al (2011)12 used data from Kaiser Permanente Hospital System in Northern California
(n=22351) to examine this association. They found that, compared to women who were
weight stable (± <1 BMI unit change), interpregnancy weight gain was significantly
associated with a higher risk of GDM in the second pregnancy. A gain of 1.0 – 1.9 BMI
units had odds of subsequent GDM 1.71 times (95% CI: 1.42 – 2.07); a gain of 2.0 – 2.9
BMI units had odds of subsequent GDM 2.46 times (95% CI: 2.00 – 3.02); a gain of 3.0
or more BMI units had the odds of subsequent GDM 3.40 times (95% CI: 2.81 – 4.12)12.
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Hospital-based cohort studies with larger sample sizes have been done in other countries,
specifically Belgium14 and Scotland15. The Belgian study investigated the association
between interpregnancy BMI change and the risk of GDM, gestational hypertension, and
caesarean section14. The Scottish study looked at the association between interpregnancy
BMI change and the following maternal outcomes: pre-eclampsia, gestational
hypertension, induced labor, elective caesarean, and emergency caesarean15. These
studies, similar to Villamor and Cnattingius3, categorized the exposure into groups based
on the unit change in their BMI from the first to second pregnancy, which ranged from
>1 BMI unit decrease to ≥ 3 units increase. The overall findings of these international
studies14,15 are in line with those seen with the Missouri 4-9 and Washington 10, 11 studies.
The majority of previous studies that investigated the association between
interpregnancy weight change and adverse maternal outcomes in the US utilized vital
records4-11, which underreport maternal complications compared to medical records
data27-30. In the US, hospital-based cohorts12 that investigate this association are rare;
thus, there is a gap in the literature that calls for a US hospital-based cohort with a large
sample size. Analysis of the longitudinal, retrospective Consecutive Pregnancy Study
dataset from the Eunice Kennedy Shriver National Institute of Child Health and Human
Development (NICHD) addresses this gap. The NICHD Consecutive Pregnancy study
collected data from 20 hospitals in Utah from 2002 – 2010. We examined the association
between interpregnancy BMI change and the following adverse maternal outcomes in the
second delivery: gestational hypertension; GDM; pre-eclampsia; non-repeat cesarean
section; and VBAC. In line with the findings of previous literature, we hypothesized that
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there is a positive association between interpregnancy BMI increase and the risk of
adverse maternal outcomes.

Table 1.1: Details of Missouri vital records-based cohorts: cohort years, sample size, and
exclusions4-9
Author
(year)

Getahun
(2007)4

Cohort
years
(sample
size)
1989-1997
(n=113,789)

Getahun
(2007)5

1989-1997
(n=136,884)

Hoff
(2009)6

1995-2004
(n=1,035)

Mostello
(2010)7

1989-2005
(n=17,773)

Whiteman 1989-2005
(2011)8
(n=232,272)
Whiteman 1989-2005
(2011)9
(n=100,828)

Study sample exclusion criteria

Those with only 1 pregnancy during study period; those
that were not nulliparous at baseline; multiple births;
stillbirths; missing data: maternal weight and height, births
at <20 weeks gestation, cesarean; vaginal birth after
cesarean (VBAC); repeated cesarean
Those with only 1 pregnancy during study period; those
that were not nulliparous at baseline; multiple births;
missing data: maternal height and weight; those with:
chronic hypertension, chronic/gestational diabetes, preeclampsia in first pregnancy, pregnancies <20 weeks
gestation
If their prepregnancy BMI was not classified overweight
(BMI 25.0 – 29.9 kg/m2) for the first pregnancy; those with
only 1 pregnancy during study period; those that were not
nulliparous at baseline; multiple births
Those with only 1 pregnancy during study period; those
that were not nulliparous at baseline; multiple births; those
whose first pregnancy was not complicated by preeclampsia
Those with only 1 pregnancy during study period; those
that were not nulliparous at baseline; births at <20 weeks
gestation
Those with only 1 pregnancy during study period; those
that were not nulliparous at baseline; those that were
classified as overweight for either pregnancy; births at <20
weeks gestation; those without vaginal birth for first
pregnancy
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Table 1.2: Details of Missouri vital records-based cohorts: outcomes and main findings4-9
Author
(year)
Getahun
(2007)4

Outcome(s)
in second
pregnancy
Primary
cesarean

Main findings

Increase in BMI from underweight to overweight or obese
within the first two pregnancies associated with increased
risk of primary cesarean (odds ratio (OR) 1.20 to 3.04)) in
second delivery
Getahun
Pre-eclampsia Risk for pre-eclampsia increased when BMI category in
(2007)5
incidence
first pregnancy was underweight and change to obese in
second pregnancy (OR: 5.6 (95% CI: 1.7 18.2); normal to
overweight (2.0 (1.7, 2.3); normal to obese (3.2 (2.5, 4.2);
overweight to obese (3.7 (3.1, 4.3)
Hoff
Pregnancy
Upward BMI shift significantly associated with
(2009)6
hypertension; emergency cesarean section (p-value <0.02)
emergency
cesarean
section
Mostello
Recurrent
Increase in BMI significantly associated with higher risk
(2010)7
pre-eclampsia of recurrent pre-eclampsia (risk ratio (RR): 1.29 (95% CI:
1.20, 1.38); decrease in BMI significantly associated with
lower risk of recurrent pre-eclampsia (RR: 0.70 (0.60,
0.81))
Whiteman Development Mothers who moved from normal to obese BMI
(2011)8
of diabetes
categories between pregnancies had increased risk (OR:
(gestational
3.21 (2.76, 3.73)) of developing diabetes in the second
or type II
pregnancy
diabetes
mellitus)
Whiteman Primary
Mothers who moved from normal to obese BMI
9
(2011)
cesarean
categories between pregnancies had increased risk (OR:
(emergency
1.41 (1.26, 1.57)) of cesarean delivery in the second
and nonpregnancy; mothers who maintained obese status between
emergency)
pregnancies also at increased risk (OR: 1.75 (1.65, 1.87)
of cesarean delivery in the second pregnancy
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CHAPTER 2
METHODS
2.1 STUDY POPULATION
The NICHD Consecutive Pregnancy Study enrolled a total of 51,086 women,
regardless of their parity, with at least two pregnancies (range 2-6 pregnancies) who
delivered between the years 2002 to 2010, which resulted in 114,679 pregnancies (live
births or stillbirths ≥ 20 weeks’ gestation). Data sources included electronic medical
records (EMR) and ICD-9 codes collected from maternal and newborn discharge
summaries and linked to each delivery. Extensive information on maternal demographic,
reproductive and medical history, pregnancy complications, labor and delivery
information, and neonatal outcomes were available. All study sites had approval for the
study and waiver of informed consent from their individual institutional review boards.
2.2 DATA EXCLUSIONS
For the current study, the sample was restricted to each woman’s first two
singleton births (n=49,868) regardless of her parity upon enrollment in the study. Women
with inconsistencies in their hypertensive status, such as being prescribed hypertensive
medication or having hypertension as a labor indication without having hypertension
(n=202); inconsistencies in their diabetes status, such as having an ICD-9 code for ‘infant
of a diabetic mother’ with no diabetes recorded for the mother (n=23); with chronic
diseases in their first pregnancy including diabetes mellitus, chronic hypertension, or
superimposed pre-eclampsia (n = 920); with missing height or weight data in either
pregnancy (n = 1546); with implausible BMI values, which was defined as
8

11 kg/m2 > BMI > 70 kg/m2 (n=1); and those with chronic hypertension, diabetes
mellitus, or superimposed pre-eclampsia in their second pregnancy (n=655) were
excluded resulting in 46,521 women for the current study (see figure 1). The
demographics of those missing height or weight data differed slightly from those with
data (supplementary table A.1). At the time of the second pregnancy, more of those
missing data identified as Hispanic (27.72%); characterized themselves as single
(13.91%); and smoked (4.22%), compared to those who were not missing data, who had
rates of 10.09%, 7.93%, and 3.07%, respectively. Of those missing data, fewer had
private insurance (61.06%) than those who were not missing data (74.16%). Those
missing data had a higher incidence of gestational diabetes mellitus in the second
pregnancy (5.89%) than those who were not missing data (3.54%). The incident rates of
the other maternal second pregnancy outcomes did not differ substantially between the
two groups (supplementary table A.1).
2.3 INTERPREGNANCY BMI CHANGE
The exposure, interpregnancy weight change, was calculated as the difference
between the prepregnancy BMI of the first pregnancy and the prepregnancy BMI of the
second pregnancy and was examined as both a continuous and a categorical variable as:
difference in BMI <-1 units (i.e. loss of more than 1 BMI unit (kg/m2)), -1 to less than 1
(reference group), 1 to less than 2, 2 to less than 3, and ≥ 3 BMI units (i.e. gain of 3 or
more BMI units).
2.4 MATERNAL OUTCOMES
Maternal outcomes in the second pregnancy were ascertained from electronic
medical records supplemented with ICD-9 codes and included: pre-eclampsia, gestational

9

hypertension, gestational diabetes, vaginal birth after cesarean delivery (VBAC), and
non-repeat cesarean delivery. If the condition was coded in either source, then the woman
was coded as having the diagnosis. During the study period, the definitions that were
widely adopted in US clinical practice were utilized to identify the outcomes of interest.
These definitions were as follows: pre-eclampsia and gestational hypertension defined as
systolic blood pressure ≥ 140 mmHg, a diastolic blood pressure ≥ 90 mmHg occurring
after 20 weeks’ gestation among previously normotensive women with and without
proteinuria and urinary excretion ≥ 0.3 grams of protein in 24-hour urine specimen,
respectively17, 18. Mode of delivery (VBAC or non-repeat cesarean delivery (C-section))
was determined via the EMR. The denominator for the VBAC outcome was restricted to
only include those who had a C-section in their first delivery (n=5132). Those with a Csection in the first delivery were excluded from the non-repeat cesarean delivery
denominator (n=41389). Gestational diabetes was determined via diagnosis in the EMR
and was supplemented with ICD-9 codes. ICD-9 codes for the examined maternal
outcomes are listed in the supplementary table A.2.
2.5 STATISTICAL ANALYSIS
Potential confounders of the association between interpregnancy BMI change and the
maternal outcomes are as follows: maternal race (categorized as: White; Hispanic; or
Black/Asian/Pacific Islander/other); maternal age (measured at pregnancy 2);
interpregnancy interval (measured as days between first delivery date and last menstrual
period for second pregnancy); smoking and alcohol use during the second pregnancy
(yes/no); pre-eclampsia, gestational hypertension, or gestational diabetes mellitus in the
first pregnancy (yes/no); and first prepregnancy BMI. Because there is potentially more
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variability in diagnosis between hospitals, the association was also adjusted for hospital
site.
Poisson regression models with robust variance estimators were used to estimate
the relative risk of the outcome while adjusting for these potential confounders19.
Unadjusted and adjusted analyses were performed for each outcome, for which two
Poisson regression models were built, treating interpregnancy BMI change as either
categorical or continuous. Significance was evaluated at α = 0.05.
Two sensitivity analyses were performed utilizing the same approach described
above. The first sensitivity analysis restricted the sample to women who were nulliparous
upon entry in the study (n=25429). Next, a sensitivity analysis was performed in which
women who had any of the examined outcomes in their first pregnancy were excluded
(gestational hypertension: n=1784; pre-eclampsia: n=1516; GDM: n=914). Of the women
in this sample, 50 had both GDM and pre-eclampsia in their first pregnancy; 42 had both
gestational hypertension and GDM in their first pregnancy. The final sample size was
n=42399. Statistical analyses were conducted using software (SAS, version 9.4; SAS
institute, Cary, NC).

11

Figure 2.1: Study Sample Exclusions
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CHAPTER 3
RESULTS
Study participants gained an average of 0.81 BMI units (median 0.46, interquartile range
(IQR) -0.34 to 1.77) over an average interpregnancy interval of 634 days (median 561,
IQR 373 to 814). At the first prepregnancy measurement, 20.69% of women were
overweight (25 ≤ BMI < 30) and 11.97% of women were obese (BMI ≥ 30). While, at the
second prepregnancy measurement 23.16% of women were overweight and 15.92% of
women were obese. At the time of the second pregnancy, most study participants were
married (90.42%); had private insurance (74.16%); identified as White (87.05%); had a
vaginal birth in their second delivery (78.54%); and were nulliparous upon entry into the
study (54.66%). The average age of the women at the second delivery was 28 years old
(median 28, IQR 25 to 31). Women who identified as single had the highest mean change
in BMI (1.50 BMI units (standard deviation (SD) = 3.02)), compared to women who
identified as married or divorced/widowed. Hispanic women had the highest mean
change in BMI (1.32 (SD: 2.73)), compared to women who identified as White, Black,
Asian, Pacific Islander, or other. Women who had pregnancy complications in the second
pregnancy including GDM, gestational hypertension, or preeclampsia gained on average
around 1.4 to 1.5 (SD: 2.9) BMI units. The sample characteristics of the study
participants are described in table 3.1.
Within the study population, the incidence rates of maternal outcomes in the
second pregnancy were as follows: gestational hypertension: 2.31%; GDM: 3.54%; pre-
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eclampsia: 1.70%; non-repeat C-section: 2.09%; VBAC: 16.02% (table 3.2). The greatest
frequency of most of the outcomes was seen among those with the largest increase in
interpregnancy BMI (≥ +3 units, n=6376). Within this group at the second delivery,
5.87% had GDM; 4.39% had gestational hypertension; 3.12% had pre-eclampsia; 1.87%
had a non-repeat C-section; and 10.51% had a VBAC (table 3.2).
After adjusting for potential confounders, for every one unit increase in BMI
between consecutive pregnancies, the risk of having GDM (relative risk (RR): 1.09 (95%
CI: 1.07 – 1.11)), pre-eclampsia (RR: 1.06 (95% CI: 1.04 – 1.09)), and gestational
hypertension in the second pregnancy increased (RR: 1.08 (95% CI: 1.06 – 1.10); while,
the risk of having a successful VBAC decreased (RR: 0.95 (95% CI: 0.93 – 0.98)) (table
3.3). There was no significant association seen between interpregnancy BMI change and
a non-repeat C-section. When interpregnancy BMI change was treated categorically, a
similar trend was seen (table 3.4). A woman with an interpregnancy BMI gain of 3 or
more units was at a higher risk of developing GDM (relative risk (RR): 1.72, 95% CI:
1.52 – 1.93), pre-eclampsia (RR: 1.61, 95% CI: 1.33 – 1.94), gestational hypertension
(RR: 1.66, 95% CI:1.42 – 1.93), than those who maintained their interpregnancy BMI,
after adjusting for potential confounders (table 3.4). A woman with an interpregnancy
BMI gain of 3 or more units was less likely to have a successful VBAC (RR: 0.72 (95%
CI: 0.58 – 0.88), than those who maintained their interpregnancy BMI, after adjusting for
potential confounders (table 3.4). This group’s risk of a non-repeat C-section did not
differ from those who maintained their BMI between consecutive pregnancies after
potential confounders were considered (table 3.4).
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Compared to those who maintained their BMI between pregnancies (-1 ≤ BMI
unit change < +1), those who increased their BMI by at least 2 units but not more than 3
units showed an increased risk of having GDM in the second pregnancy (RR: 1.40 (95%
CI: 1.22 – 1.61)), after adjusting for potential confounders (table 3.4). This group did not
differ in their risk of pre-eclampsia, gestational hypertension, non-repeat C-section, or
VBAC, in comparison to those who maintained their BMI between pregnancies, after
potential confounders were considered (table 3.4).
Compared to those who maintained their BMI between pregnancies, those who
gained +1 ≤ BMI unit < 2 were at a higher risk of having GDM in the second pregnancy
(RR: 1.23 (95% CI: 1.08 – 1.40)) and at a higher risk of having an unsuccessful VBAC
(RR: 0.77 (95% CI: 0.64 – 0.94), after adjusting for potential confounders (table 3.4).
This group’s risk of pre-eclampsia, gestational hypertension, and non-repeat C-section
did not differ from those who maintained their BMI between consecutive pregnancies,
after potential confounders were considered (table 3.4).
Weight loss of more than one BMI unit between consecutive pregnancies was not
significantly associated with an increased risk of GDM, pre-eclampsia, gestational
hypertension, non-repeat cesarean section, or VBAC, after adjusting for potential
confounders (table 3.4).
The results of the two sensitivity analyses did not differ from the findings of the
full data. The findings for the nulliparous sensitivity analyses are reported for BMI
change as continuous (table 3.5) and as categorical (table 3.6). Of the nulliparous sample,
739 (2.91%) had GDM; 599 (2.36%) had gestational hypertension; 2 (<0.01%) had a
non-repeat C-section; 619 (14.01%) had a VBAC; and 465 (1.83%) had pre-eclampsia.
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Similarly, the findings for excluding women who had any outcome in the first pregnancy
(GDM, gestational hypertension, pre-eclampsia) are reported for BMI change as
continuous (table 3.7) and as categorical (table 3.8). In this second sensitivity analysis,
812 (1.92%) had GDM; 587 (1.38%) had gestational hypertension; 828 (2.17%) had a
non-repeat C-section; 741 (17.35%) had a VBAC; and 464 (1.09%) had pre-eclampsia.
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Table 3.1: Sample Characteristics of NICHD Consecutive Pregnancy Study from 20 hospitals in Utah
(n=46521)
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Characteristic
First pregnancy BMI category, n (%)
Underweight (BMI < 18.5)
Normal (18.5 ≤ BMI < 25)
Overweight (25 ≤ BMI < 30)
Obese (BMI ≥ 30)
Marital status, n (%)
Married
Divorced/Widowed
Single
Private insurance, n (%)
Maternal race, n (%)
White
Hispanic
Black/Asian/Pacific Islander/Other
Lifestyle behaviors
Smoking during pregnancy 2, n (%)
Alcohol use during pregnancy 2, n (%)
Gestational diabetes mellitus, n (%)
Gestational hypertension, n (%)
Pre-eclampsia, n (%)
Delivery mode, n (%)
Vaginal birth
Vaginal birth after cesarean in first delivery
Non-repeat cesarean in second delivery
Repeat cesarean in second delivery
*Chi-square test

Second Pregnancy

p-value*
<0.0001

2738 (5.89)
28591 (61.46)
9623 (20.69)
5569 (11.97)

Mean change in BMI (SD)
0.95 (1.64)
0.77 (1.94)
0.97 (2.73)
0.74 (3.56)

<0.0001
42063 (90.42)
767 (1.65)
3742 (7.93)
34498 (74.16)

<0.0001
<0.0001

40457 (87.05)
4691 (10.09)
1328 (2.86)
1427 (3.07)
696 (1.50)
1646 (3.54)
1073 (2.31)
791 (1.70)
36539 (78.54)
1685 (3.62)
1603 (3.45)
6693 (14.39)

0.75 (2.26)
0.98 (3.06)
1.50 (3.02)
0.69 (2.18)
0.74 (2.29)
1.32 (2.73)
1.28 (2.72)

<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001

1.07 (3.12)
1.03 (2.86)
1.39 (2.85)
1.54 (2.88)
1.42 (2.92)
0.77 (2.26)
0.69 (2.22)
0.94 (2.64)
1.07 (2.77)

Table 3.1 continued: Sample characteristics of NICHD Consecutive Pregnancy Study from 20
hospitals in Utah (n=46521)
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Characteristic
Maternal age, years, n (%)
< 35
≥ 35
Maternal age, years, mean (SD)
Parity
1
2
3
4
5
6+
Interpregnancy interval
0 – 5 months
6 – 11 months
12 – 17 months
18 – 23 months
24 – 59 months
≥ 60 months
Interpregnancy interval, months, mean (SD)
*Chi-square test

Second Pregnancy

p-value*
<0.0001

42268 (90.86)
4253 (9.14)
27.97 (4.63)

Mean change in BMI (SD)
0.83 (2.37)
0.68 (2.23)

<0.0001
25429 (54.66)
10624 (22.84)
6461 (13.89)
2507 (5.39)
925 (1.99)
575 (1.24)

0.90 (2.43)
0.75 (2.26)
0.68 (2.26)
0.71 (2.24)
0.67 (2.27)
1.18 (1.89)
<0.0001

2402 (5.16)
7536 (16.20)
11065 (23.78)
9630 (20.70)
15332 (32.96)
556 (1.20)
21.15 (12.31)

1.03 (2.37)
0.73 (2.24)
0.57 (2.14)
0.64 (2.23)
1.07 (2.54)
1.88 (3.36)

Table 3.2: Outcomes in second pregnancy by BMI change regardless of parity at baseline (N=46521), n (%)
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BMI unit change

GDM
n = 1646

Gestational
hypertension
n = 1073

Pre-eclampsiac
n = 791

Non-repeat
C-sectiona
n = 863

VBACb
n = 822

BMI unit change < -1
(n=6560)

228 (3.48)

134 (2.04)

114 (1.74)

120 (2.07)

121 (16.09)

-1 ≤ BMI unit change < + 1
(n=22838)

609 (2.67)

408 (1.79)

304 (1.33)

437 (2.12)

426 (19.15)

+ 1 ≤ BMI unit change < + 2
(n=6737)

239 (3.55)

151 (2.24)

108 (1.60)

119 (1.99)

103 (13.79)

+2 ≤ BMI unit change < + 3
(n=4010)

196 (4.89)

100 (2.49)

66 (1.65)

86 (2.41)

71 (15.85)

BMI unit change ≥ + 3
374 (5.87)
280 (4.39)
199 (3.12)
101 (1.87)
101 (10.51)
(n=6376)
p-valuec
<0.0001
<0.0001
<0.0001
<0.0001
<0.0001
a
Denominator excludes anyone with a c-section in the first pregnancy (n = 41389); bDenominator only includes
those with c-section in first pregnancy (n=5132); cChi-square test

Table 3.3: Relative risks (95% confidence intervals) of maternal outcomes by
BMI difference (continuous) between consecutive pregnancies (n=46521)
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Maternal Outcome in Second Pregnancy
BMI difference (continuous)
GDM
Unadjusted
1.10 (1.08 – 1.12)**
a
Adjusted
1.09 (1.07 – 1.11)**
Pre-eclampsia
Unadjusted
1.10 (1.07 – 1.13)**
Adjusteda
1.06 (1.04 – 1.09)**
Gestational hypertension
Unadjusted
1.12 (1.09 – 1.14)**
a
1.08 (1.06 – 1.10)**
Adjusted
Non-repeat C-section
Unadjusted
0.98 (0.95 – 1.00)*
a
Adjusted
0.99 (0.96 – 1.02)
VBAC
Unadjusted
0.95 (0.93 – 0.97)**
Adjusteda
0.95 (0.93 – 0.98)**
a
Adjusted for: maternal race (referent level: white); maternal age;
interpregnancy interval; smoking during 2nd pregnancy (referent level: yes);
alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st
pregnancy (referent level: yes); gestational hypertension in 1st pregnancy
(referent level: yes); GDM in 1st pregnancy (referent level: yes); prepregnancy 1 BMI; hospital site. *Marginally significant at α = 0.05 level
**Significant at α = 0.05 level

Table 3.4: Relative risks (95% confidence intervals) of maternal outcomes by BMI change (categorical) between consecutive
pregnancies (n=46521) – Referent level: - 1 unit ≤ BMI change < 1 unit

21

Maternal Outcome in
Second Pregnancy
GDM
Unadjusted
Adjusteda
Pre-eclampsia
Unadjusted
Adjusteda
Gestational hypertension
Unadjusted
Adjusteda
Non-repeat C-section
Unadjusted
Adjusteda
VBAC
Unadjusted
Adjusteda
a

BMI change < -1 unit

BMI change 1 to less
than 2 units

BMI change 2 to less
than 3

BMI change ≥ 3 units

1.30 (1.12 – 1.51)**
0.90 (0.79 – 1.02)

1.33 (1.15 – 1.54)**
1.23 (1.08 – 1.40)**

1.83 (1.57 – 2.15)**
1.40 (1.22 – 1.61)**

2.20 (1.94 – 2.49)**
1.72 (1.52 – 1.93)**

1.31 (1.05 – 1.62)**
0.97 (0.78 – 1.20)

1.20 (0.97 – 1.50)
1.03 (0.83 – 1.28)

1.24 (0.95 – 1.50)
1.00 (0.77 – 1.30)

2.34 (1.97 – 2.80)**
1.61 (1.33 – 1.94)**

1.14 (0.94 – 1.39)
0.83 (0.69 – 1.01)

1.25 (1.04 – 1.51)**
1.10 (0.91 – 1.31)

1.40 (1.12 – 1.73)**
1.10 (0.89 – 1.36)

2.46 (2.12 – 2.85)**
1.66 (1.42 – 1.93)**

0.97 (0.80 – 1.19)
0.99 (0.81 – 1.22)

0.94 (0.77 – 1.15)
0.92 (0.75 – 1.13)

1.14 (0.91 – 1.43)
1.15 (0.92 – 1.45)

0.88 (0.71 – 1.09)
1.01 (0.81 – 1.25)

0.84 (0.70 – 1.01)
1.06 (0.88 – 1.27)

0.72 (0.59 – 0.88)**
0.77 (0.64 – 0.94)**

0.83 (0.66 – 1.04)
0.98 (0.78 – 1.23)

0.55 (0.45 – 0.67)**
0.72 (0.58 – 0.88)**

Adjusted for: maternal race (referent level: white); maternal age; interpregnancy interval; smoking during 2nd pregnancy
(referent level: yes); alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st pregnancy (referent level:
yes); gestational hypertension in 1st pregnancy (referent level: yes); GDM in 1st pregnancy (referent level: yes); prepregnancy 1 BMI; hospital site. *Marginally significant at α = 0.05 level **Significant at α = 0.05 level

Table 3.5: Relative risks (95% confidence intervals) of maternal outcomes by
BMI difference (continuous) between consecutive pregnancies among
nulliparous women at baseline (n=25429)
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Maternal Outcome in Second Pregnancy
BMI difference (continuous)
GDM
Unadjusted
1.12 (1.09 – 1.14)**
1.11 (1.08 – 1.13)**
Adjusteda
Pre-eclampsia
Unadjusted
1.10 (1.06 – 1.13)**
a
Adjusted
1.06 (1.03 – 1.09)**
Gestational hypertension
Unadjusted
1.12 (1.09 – 1.15)**
Adjusteda
1.08 (1.05 – 1.10)**
Non-repeat C-section
Unadjusted
-b
-b
Adjusteda
VBAC
Unadjusted
0.95 (0.92 – 0.97)**
Adjusteda
0.95 (0.92 – 0.98)**
a
Adjusted for: maternal race (referent level: white); maternal age;
interpregnancy interval; smoking during 2nd pregnancy (referent level: yes);
alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st
pregnancy (referent level: yes); gestational hypertension in 1st pregnancy
(referent level: yes); pre-pregnancy 1 BMI; GDM in 1st pregnancy (referent
level: yes); hospital site; bModels did not converge; outcome not frequent
enough (prevalence = 2/21010); **Significant at α = 0.05 level

Table 3.6: Relative risks (95% confidence intervals) of maternal outcomes by BMI change (categorical) between consecutive
pregnancies of nulliparous women at baseline (n=25429) – Referent level: - 1 unit ≤ BMI change < 1 unit
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Maternal Outcome in
Second Pregnancy
GDM
Unadjusted
Adjusteda
Pre-eclampsia
Unadjusted
Adjusteda
Gestational hypertension
Unadjusted
Adjusteda
Non-repeat C-section
Unadjusted
Adjusteda
VBAC
Unadjusted
Adjusteda
a

BMI change < -1 unit

BMI change 1 to less
than 2 units

BMI change 2 to less
than 3

BMI change ≥ 3 units

1.06 (0.83 – 1.35)
0.87 (0.71 – 1.07)

1.33 (1.06 – 1.66)**
1.28 (1.05 – 1.56)**

1.84 (1.45 – 2.33)**
1.58 (1.27 – 1.96)**

2.24 (1.87 – 2.69)**
1.87 (1.58 – 2.23)**

1.19 (0.89 – 1.59)
0.93 (0.70 – 1.24)

1.43 (1.08 – 1.87)**
1.15 (0.88 – 1.51)

1.19 (0.84 – 1.69)
0.99 (0.70 – 1.41)

2.22 (1.78 – 2.80)**
1.52 (1.19 – 1.94)**

0.96 (0.73 – 1.26)
0.75 (0.58 – 0.98)

1.27 (0.99 – 1.62)
1.03 (0.81 – 1.32)

1.37 (1.03 – 1.83)**
1.10 (0.83 – 1.46)

2.30 (1.89 – 2.80)**
1.52 (1.24 – 1.87)**

-b
-b

-b
-b

-b
-b

-b
-b

0.92 (0.75 – 1.14)
1.17 (0.95 – 1.44)

0.74 (0.59 – 0.93)**
0.78 (0.62 – 0.98)**

0.84 (0.64 – 1.10)
1.00 (0.76 – 1.32)

0.57 (0.45 – 0.71)**
0.72 (0.57 – 0.92)**

Adjusted for: maternal race (referent level: white); maternal age; interpregnancy interval; smoking during 2nd pregnancy
(referent level: yes); alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st pregnancy (referent level:
yes); gestational hypertension in 1st pregnancy (referent level: yes); GDM in 1st pregnancy (referent level: yes); prepregnancy 1 BMI; hospital site; bModels did not converge; outcome not frequent enough (prevalence = 3/21208);
*Marginally significant at α = 0.05 level **Significant at α = 0.05 level

Table 3.7: Relative risks (95% confidence intervals) of maternal outcomes by
BMI difference (continuous) between consecutive pregnancies – excluding
those who had any outcome in the first pregnancy (n=42399)
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Maternal Outcome in Second Pregnancy
BMI difference (continuous)
GDM
Unadjusted
1.16 (1.13 – 1.18)**
1.13 (1.11 – 1.16)**
Adjusteda
Pre-eclampsia
Unadjusted
1.11 (1.07 – 1.15)**
a
Adjusted
1.08 (1.05 – 1.12)**
Gestational hypertension
Unadjusted
1.14 (1.11 – 1.18)**
Adjusteda
1.12 (1.09 – 1.15)**
Non-repeat C-section
Unadjusted
0.98 (0.95 – 1.01)
a
0.99 (0.96 – 1.02)
Adjusted
VBAC
Unadjusted
0.94 (0.92 – 0.97)**
Adjusteda
0.94 (0.91 – 0.97)**
a
Adjusted for: maternal race (referent level: white); maternal age;
interpregnancy interval; smoking during 2nd pregnancy (referent level: yes);
alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st
pregnancy (referent level: yes); gestational hypertension in 1st pregnancy
(referent level: yes); pre-pregnancy 1 BMI; GDM in 1st pregnancy (referent
level: yes); hospital site. **Significant at α = 0.05 level

Table 3.8: Relative risks (95% confidence intervals) of maternal outcomes by BMI change (categorical) between consecutive
pregnancies – excluding those who had any outcome in the first pregnancy (n=42399) – Referent level: - 1 unit ≤ BMI
change < 1 unit
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Maternal Outcome in
Second Pregnancy
GDM
Unadjusted
Adjusteda
Pre-eclampsia
Unadjusted
Adjusteda
Gestational hypertension
Unadjusted
Adjusteda
Non-repeat C-section
Unadjusted
Adjusteda
VBAC
Unadjusted
Adjusteda
a

BMI change < -1 unit

BMI change 1 to less
than 2 units

BMI change 2 to less
than 3

BMI change ≥ 3 units

1.09 (0.85 – 1.38)
0.83 (0.65 – 1.06)

1.62 (1.32 – 1.99)**
1.43 (1.16 – 1.75)**

2.09 (1.66 – 2.62)**
1.75 (1.39 – 2.19)**

2.94 (2.47 – 3.50)**
2.27 (1.88 – 2.73)**

1.13 (0.85 – 1.50)
0.84 (0.63 – 1.13)

1.11 (0.84 – 1.48)
0.98 (0.74 – 1.31)

1.04 (0.72 – 1.49)
0.87 (0.60 – 1.26)

2.24 (1.78 – 2.82)**
1.65 (1.28 – 2.13)**

1.07 (0.81 – 1.40)
0.78 (0.59 – 1.02)

1.35 (1.05 – 1.72)**
1.24 (0.97 – 1.59)

1.20 (0.87 – 1.65)
1.03 (0.75 – 1.42)

2.90 (2.38 – 3.53)**
2.23 (1.81 – 2.75)**

1.00 (0.82 – 1.23)
1.01 (0.82 – 1.25)

0.94 (0.76 – 1.15)
0.91 (0.74 – 1.12)

1.13 (0.89 – 1.43)
1.12 (0.89 – 1.42)

0.90 (0.72 – 1.12)
1.00 (0.80 – 1.25)

0.88 (0.73 – 1.06)
1.10 (0.91 – 1.33)

0.73 (0.59 – 0.90)**
0.79 (0.64 – 0.97)**

0.85 (0.66 – 1.08)
0.97 (0.76 – 1.23)

0.53 (0.43 – 0.67)**
0.68 (0.54 – 0.85)**

Adjusted for: maternal race (referent level: white); maternal age; interpregnancy interval; smoking during 2nd pregnancy
(referent level: yes); alcohol use during 2nd pregnancy (referent level: yes); Pre-eclampsia in 1st pregnancy (referent level:
yes); gestational hypertension in 1st pregnancy (referent level: yes); GDM in 1st pregnancy (referent level: yes); prepregnancy 1 BMI; hospital site. *Marginally significant at α = 0.05 level **Significant at α = 0.05 level

CHAPTER 4
DISCUSSION
We found that there was a significant association between a one unit increase in BMI
between consecutive pregnancies and increased risk of GDM, gestational hypertension,
pre-eclampsia, and an unsuccessful VBAC in the second pregnancy when potential
confounders were taken into consideration. No association was found between
interpregnancy BMI change and non-repeat C-section. The highest magnitude of risk of
these adverse maternal outcomes was seen when comparing the group with the largest
increase in interpregnancy BMI (≥ +3 units), which for this study was representative of
13.79% of participants, with those who maintained their interpregnancy BMI (-1 unit ≤
BMI change < 1 unit), which was representative of 49.38% of participants. Overall, the
results of the current study were in line with findings of previous studies3-12, 14, 15;
however, it must be noted that all of the previous studies except for one12 utilized vital
records data, which tend to underreport maternal complications27-30 compared to medical
records.
4.1 GESTATIONAL DIABETES MELLITUS (GDM)
We found that any increase in BMI between consecutive pregnancies was significantly
associated with an elevated risk of GDM, compared with those who maintained their
BMI. We found that a BMI increase of ≥ 3 units had a risk 1.72 (95% CI: 1.52 – 1.93)
times that of those who maintained their BMI. When comparing those same groups,
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Villamor and Cnattingius found an odds ratio of GDM in the second pregnancy of 2.09
(95% CI: 1.68 – 2.61)3. Although both Whiteman et al8 and Ehrlich et al12 categorized
their exposures differently, they found significant associations between an increase in
BMI and an increase of GDM risk in the second pregnancy. Bogaerts et al14 found that
this association was only significant in those who had a BMI < 25 at the first
prepregnancy measurement. Unlike the findings of the current study, both Whiteman et
al8 and Ehrlich et al12 found that as BMI decreased between consecutive pregnancies, the
odds of GDM in the second pregnancy decreased. However, Ehrlich et al12 only found
this amongst women who were categorized as overweight or obese in their first
pregnancy. Also, because Whiteman et al8 categorized their exposure differently, it may
be difficult to compare their results to the current study.
4.2 PRE-ECLAMPSIA
We found that an increase in BMI between consecutive pregnancies was associated with
an increased risk of pre-eclampsia in the second pregnancy. A BMI increase of ≥ 3 units
(compared to interpregnancy BMI maintenance) was associated with a RR of 1.61 (95%
CI: 1.33 – 1.94) of pre-eclampsia. Villamor and Cnattingius3 and Wallace et al15
categorized the exposure the same way we did and found that if a woman increases her
BMI ≥ 3 units between consecutive pregnancies, her odds of pre-eclampsia in the second
pregnancy increases. Although Getahun et al5 categorized their exposure differently than
our current study, they found a similar positive significant association. Mostello et al7
only looked at recurrent pre-eclampsia in the second pregnancy. Similar to our results,
they found that as BMI increases, the odds of pre-eclampsia in the second pregnancy
increases. However, they also found that as BMI decreases, the odds of pre-eclampsia
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decreases. As they only included those with pre-eclampsia in their first pregnancy, it may
not be appropriate to compare the results of Mostello et al7 to our results.
4.3 GESTATIONAL HYPERTENSION
We found that a BMI increase of ≥ 3 units between consecutive pregnancies had an
elevated risk of gestational hypertension in the second pregnancy 1.66 times that of
women who maintained their weight (95% CI: 1.42 – 1.93). Both Villamor and
Cnattingius3 and Wallace et al15 found a similar positive, significant association when
comparing women whose BMI increased ≥ 3 units between consecutive pregnancies
compared to those who maintained their weight. Bogaerts et al14 found a positive,
significant association when comparing the same groups above at a higher magnitude
(OR: 3.76 (95% CI: 2.16 – 6.57), but this was only seen in women whose first
prepregnancy BMI was < 25 kg/m2. Hoff et al9 did not find any association between
interpregnancy BMI change and the risk of gestational hypertension in the second
pregnancy; however, they only included women who were overweight at their first
prepregnancy measurement.
4.4 NON-REPEAT CESAREAN DELIVERY
We found no association between interpregnancy BMI change and risk of non-repeat Csection. Several previous studies explored this same association but had mixed results.
Villamor and Cnattigius3 found that those with a BMI increase of ≥ 3 units (compared to
interpregnancy BMI maintenance) had odds of 1.32 (95% CI: 1.22 - 1.44) of a C-section
in their second delivery. Villamor and Cnattingius3 did not exclude women with a Csection in their first delivery from the denominator of their analysis. Although Getahun et
al4 and Whiteman et al9 categorized their exposure differently than Villamor and
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Cnattingius3 did, they found the same trend that as BMI increased so did odds of a nonrepeat C-section in the second delivery. Both Hoff et al6 and Bogaerts et al14 found that
the association between increase in BMI and risk of C-section in the second pregnancy
was only significant if women were categorized as overweight or obese in their first
pregnancy. Although Paramsothy et al10 only included women with GDM in their first
pregnancy, they also found that as BMI increases so does risk of C-section in the second
delivery. Wallace et al15 did not find an association between an increase in BMI and the
risk of neither elective nor emergency C-section in the second delivery; however,
Wallace et al15 did not look at the outcome as a ‘non-repeat’ C-section as we did in the
current study.
4.5 VAGINAL BIRTH AFTER CESAREAN DELIVERY (VBAC)
We found that a BMI increase of ≥ 3 units between consecutive pregnancies had a
decreased rate of VBAC success (RR: 0.72 (95% CI: 0.58 – 0.88)). Only one of the
previous studies explored this association and had similar results to ours11. Callegari et
al11 found that those who increased their BMI ≥ 1 unit or < 2 units had an 8% decrease in
VBAC success (95% CI: 2-13%). Similarly, they found that those who increased their
BMI ≥ 2 units had a 12% decrease in VBAC success (95% CI: 7-17%)11. Their analysis
only included women who were nulliparous at their first pregnancy11.
4.6 FURTHER DISCUSSION
The incidence rates of the outcomes measured in the current study were less than the
national estimates18, 21. The discrepancy between these incident rates can be explained by
the overall health status of the study population (Utah based) being better than the
national population24.

29

Significant associations were found between interpregnancy BMI increase of 3 or
more units and GDM, gestational hypertension, pre-eclampsia, and unsuccessful VBAC,
when compared to those who maintained their interpregnancy BMI. To put this
comparison into perspective, the Centers for Disease Control and Prevention reports that
the average height of US women who are 20 years old and over is 162.1 cm20. For a
woman of average height, a BMI unit change of 3 units is equivalent to gaining
approximately 17.38 pounds between consecutive pregnancies.
The biological mechanisms to explain the association between interpregnancy
BMI gains and the adverse maternal outcomes of interest are speculative at best. Ros et al
(1998)25 suggest that BMI impacts lipid metabolism, which in turn elevates the level of
free fatty acids. As this level increases, insulin resistance increases via tumor necrosis
factor alpha. This resulting insulin resistance is counteracted by hyperinsulinemia, which
causes vasoconstriction. This vasoconstriction eventually leads to hypertension, which
could be transient, i.e. gestational, or can become chronic. Ros et al (1998)25 also report
that tumor necrosis factor alpha has been found to be at higher levels in pre-eclamptic
women, which leads to endothelial dysfunction. The resulting insulin resistance
mentioned above could also result in GDM, which is the manifestation of underlying beta
cell dysfunction16. Again, these associations are hypothetical, but these adverse outcomes
and obesity share several characteristics, such as inflammatory biomarkers, oxidative
stress, and dyslipidemia26. Future research into the physiological biomarkers of these
factors is needed26.
The main strength of the current study was the combination of both EMRs and
ICD-9 codes as data sources, which allowed us to gather extensive demographic,

30

diagnostic, and history information about study participants and many different
outcomes. Further, as previously described, the majority of the previous studies that
investigated the association between interpregnancy BMI change and adverse maternal
outcomes utilized vital records data for analysis, which tend to underreport maternal
complications27-30. Another strength of the current study was that the study population is
homogeneous reducing the potential for residual confounding of the association of
interest. The large sample size and retrospective US-based cohort design are further
strengths of the current study. Unlike the Missouri cohort studies4-9 and Callegari et al11,
we included women regardless of their parity. The results of the first sensitivity analysis,
which only included nulliparous women, showed that there is no change in the magnitude
and direction of the association between these two groups based on parity. Unlike several
of the previous studies, the current study utilized Poisson regression with robust variance
estimators allowing us to estimate relative risk, instead of odds ratios, as was done in
previous studies3-6, 8-12, 14, 15.
One limitation of the current study was the lack of information on diet, physical
activity, and prenatal care of the study participants. Similarly, we lacked information
about family history of hypertension and diabetes mellitus, as well as paternity, which
may impact a woman’s risk of an adverse outcome in her second pregnancy. Change in
paternity has been associated with elevated odds of pre-eclampsia23, but since the
majority of the women in the current study were married, i.e. in stable relationships, at
the time of the second pregnancy (90.42%), we do not expect this to impact our risk
estimates. The prevalence of married women in the current study is higher than the
national estimate of 41.5%24. The current study population was also predominantly white
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(87.05%); thus, the generalizability of our findings is limited. The homogeneity of the
population also limited our ability to analyze whether race was an effect modifier of the
association of interest. Another limitation of the current study was that weight was selfreported. However, because the exposure of interest was a difference in weight
measurement between two consecutive pregnancies, this should not over or
underestimate the exposure31-33.
In conclusion, this retrospective, US-based cohort study filled a gap in the
literature and provided evidence that there was a significant association between
interpregnancy BMI gain and the risk of adverse maternal outcomes: gestational
hypertension, pre-eclampsia, gestational diabetes mellitus, and unsuccessful VBAC,
when comparing those with the highest BMI change (≥ +3 units) and those who
maintained their BMI between pregnancies (-1 unit ≤ BMI < +1 unit). These findings are
in line with previous studies and have public health implications for the importance of
weight management between pregnancies.
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APPENDIX A: SUPPLEMENTARY TABLES
Table A.1: Comparison of the demographics of those missing BMI data and those not
missing BMI data
Characteristic of the second pregnancy Missing BMI
(n = 1546)
Marital status, n (%)
Married
1303 (84.28)
Divorced/Widowed
27 (1.75)
Single
215 (13.91)
Private insurance, n (%)
944 (61.06)
Maternal race, n (%)
White
1038 (67.23)
Hispanic
428 (27.72)
Black/Asian/Pacific Islander/Other
1370 (5.05)
Lifestyle behaviors
Smoking during pregnancy 2, n (%)
65 (4.22)
Alcohol use during pregnancy 2, n
30 (1.95)
(%)
Gestational diabetes mellitus, n (%)
91 (5.89)
Gestational hypertension, n (%)
37 (2.39)
Pre-eclampsia, n (%)
21 (1.36)
Delivery mode, n (%)
Vaginal birth
1195 (77.30)
Vaginal birth after cesarean in first
69 (4.46)
delivery
Non-repeat cesarean in second
53 (3.43)
delivery
Repeat cesarean in second delivery
229 (14.81)
Maternal age, years, n (%)
< 35
1365 (88.29)
≥ 35
181 (11.71)
Maternal age, years, mean (SD)
27.90 (4.50)
*Chi-square test
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Not missing BMI
(n = 46521)

p-value*
<0.0001

42063 (90.42)
767 (1.65)
3742 (7.93)
34498 (74.16)

<0.0001
<0.0001

40457 (87.05)
4691 (10.09)
1328 (2.86)
1427 (3.07)
696 (1.50)

<0.0001
0.1568

1646 (3.54)
1073 (2.31)
791 (1.70)

<0.0001
0.0673
0.8434
0.0046

36539 (78.54)
1685 (3.62)
1603 (3.45)
6693 (14.39)
<0.0001
42268 (90.86)
4253 (9.14)
27.97 (4.63)

Table A.1 continued: Comparison of the demographics of those missing BMI data and
those not missing BMI data
Characteristic of the second pregnancy Missing BMI
(n = 1546)
Parity
1
772 (49.94)
2
359 (23.22)
3
250 (16.17)
4
102 (6.60)
5
35 (2.26)
6+
27 (1.81)
Interpregnancy interval
0 – 5 months
137 (8.86)
6 – 11 months
297 (19.21)
12 – 17 months
359 (23.22)
18 – 23 months
250 (16.17)
24 – 59 months
489 (31.63)
≥ 60 months
14 (0.91)
*Chi-square test
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Not missing BMI
(n = 46521)

p-value*
0.0005

25429 (54.66)
10624 (22.84)
6461 (13.89)
2507 (5.39)
925 (1.99)
575 (1.24)
<0.0001
2402 (5.16)
7536 (16.20)
11065 (23.78)
9630 (20.70)
15332 (32.96)
556 (1.20)

Table A.2: ICD-9 codes for maternal outcomes
Outcome
Pre-eclampsia
Gestational
hypertension
Gestational diabetes

Chronic hypertension

ICD-9 code
642.4
642.5
642.3

Definition
Mild or unspecified pre-eclampsia
Severe pre-eclampsia
Transient hypertension of pregnancy

648.8

Abnormal glucose tolerance of mother
complicating pregnancy, childbirth, or the
puerperium
Essential hypertension
Malignant essential hypertension
Benign essential hypertension
Unspecified essential hypertension
Hypertensive heart disease
Malignant hypertensive heart disease
Benign hypertensive heart disease
Unspecified hypertensive heart disease
Hypertensive chronic kidney disease
Malignant hypertensive renal disease
Benign hypertensive renal disease
Unspecified renal disease
Hypertensive heart and chronic kidney
disease
Malignant hypertensive heart and renal
disease
Benign hypertensive heart and renal disease
Unspecified hypertensive heart and renal
disease
Secondary hypertension
Malignant secondary hypertension
Benign secondary hypertension
Unspecified secondary hypertension
Hypertension complicating pregnancy and
childbirth and the puerperium
Benign essential hypertension
Hypertension secondary to renal disease
Other pre-existing hypertension

401
401.0
401.1
401.9
402
402.0
402.1
402.9
403
403.0
403.1
403.9
404
404.0
404.1
404.9
405
405.0
405.1
405.9
642
642.0
642.1
642.2
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